GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile
Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease
Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer
CMX001 Reduces Adenovirus Progression and Viremia
Biomarker Identified Predicting Graft-Versus-Host Disease Risk
Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan
Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival
Pretreatment with Azacitidine Achieves 28-Month Remission
Specific Pathology Pattern Can Predict Recurrence
20% of Women Do Not Believe Tailored Risk Assessments
Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer
Study Finds Gene Expression Test Predicts Stage I or II Recurrence
NCI CTEP Approved Trials For the Month of August
FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Lei Zheng named executive director of Mays Cancer Center
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”